DAT binding in PD is commonly asymmetric, and the loss of binding is generally more profound in the putamen than in the caudate nucleus, which is also the case in this study, thus confirming the findings of earlier DAT SPECT studies in PD [20,23]. Here, SLC6A3 is linked to Parkinson disease.